This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold Prudential (PRU) Stock For Now
by Zacks Equity Research
Prudential (PRU) continues to benefit from business growth, higher variable investment income, prudent capital deployment and solid capital position.
Why Should You Hold Lincoln National (LNC) in Your Portfolio?
by Sapna Bagaria
Declining pandemic headwinds and an improving economy place Lincoln National (LNC) on a stable growth path.
7 Insurers That Are Likely to Deliver Q2 Earnings Beat
by Tanuka De
Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help AXS, NMIH, MET, ATH, VOYA, MMC, and AFL outperform Q2 earnings estimates.
Top 5 Picks With Dividend Yield Higher Than 10-Year Note Yield
by Nalak Das
We have narrowed down our search to five large-cap stocks with current dividend yield of more than 3%. These are: REG, ET, MET, IP and BX.
Here's Why You Should Add MetLife (MET) to Your Portfolio
by Zacks Equity Research
Improving economy, receding COVID-19 claims and business restructuring make MetLife (MET) an attractive investment bet.
MetLife (MET) Launches Pet Insurance Product, Boosts Portfolio
by Zacks Equity Research
MetLife (MET) introduces a pet insurance product, which intends to offer enhanced care for pets and address financial stress of pet parents.
Horace Mann (HMN) Ups 2021 Guidance on Strong Q2 Expectation
by Zacks Equity Research
Horace Mann (HMN) estimates 2021 EPS between $3.50 and $3.70, an increase of 15% from $3.00 and $3.20 guided earlier.
Zacks.com featured highlights include: Boise Cascade, USA Truck, PetroChina Co, Berry Global Group and MetLife
by Zacks Equity Research
Zacks.com featured highlights include: Boise Cascade, USA Truck, PetroChina Co, Berry Global Group and MetLife
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Pick These 5 Bargain Stocks With Alluring EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks BCC, USAK, PTR, BERY and MET based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Radian Group (RDN) Up 51% in a Year: More Room for Upside?
by Zacks Equity Research
Solid mortgage insurance portfolio and improving risk-based capital ratio are likely to continue aiding Radian Group (RDN).
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like NUS, FL, SIG, MET, MT, VSH and SMP are promising picks.
MetLife (MET) Keeps Streamlining Business by Partial Sell-Offs
by Zacks Equity Research
MetLife (MET) to divest its Europe business partly to zero in on core growth areas.
Can Value Investors Consider MetLife (MET) Stock Now?
by Zacks Equity Research
Is MetLife (MET) a great pick from the value investor's perspective right now? Read on to know more.
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDIV
Lincoln National's (LNC) Measures to Offer Customized Retirement Plans
by Zacks Equity Research
Lincoln National (LNC) takes initiatives to offer better personalization options for investment plans offered through Morningstar Investment Management's advisor managed accounts service.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why MetLife (MET) is Poised for a Turnaround After Losing 6.5% in 4 Weeks
by Zacks Equity Research
MetLife (MET) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Radian (RDN) Boosts Mortgage Service With Mortgage Cadence
by Zacks Equity Research
Radian Group (RDN) integrates with Mortgage Cadence to boost the mortgage and real estate transaction.
7 Insurance Stocks to Bet on Even As Fed Keeps Rates Unchanged
by Tanuka De
In a low interest rate environment, insurers like ALL, MET, HUM, MFC, ORI, HMN, HCI are best investment bets given their fundamental strength.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Assurant (AIZ) Prices 2.650% $350 Senior Unsecured Notes
by Zacks Equity Research
Assurant (AIZ) displays prudence by issuing senior notes amid a low interest rate environment to procure funds.
MetLife (MET) Down 0.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: American International Group, Cigna Corp, MetLife and Prudential Financial
by Zacks Equity Research
Zacks Industry Outlook Highlights: American International Group, Cigna Corp, MetLife and Prudential Financial
Here's How Guidewire (GWRE) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Guidewire's (GWRE) fiscal third-quarter results are likely to reflect gains from continued momentum in InsuranceSuite as well as data and analytics solutions.